Clinical Trials Logo

Clinical Trial Summary

PEG is a fusogen, a type of chemical that aids in mediating cell fusion. PEG helps nerve cells recover neuronal continuity by removing plasmalemmal-bound water which opens the axonal ends on both sides of the injury. Opening axonal ends permits the nerve ends to reconnect and begin regeneration. PEG has been tested on animal models extensively and in earthworm models has been shown to induce fusion rates in 80-100% of neuronal cells. In crushed or severed mammalian sciatic nerves PEG has enhanced neuronal continuity to baseline functioning levels. Human applications for PEG have been tested by Bamba and colleagues in a case series with encouraging results. No studies, to our knowledge, have prospectively examined the use of PEG in peripheral nerve injuries. We propose a placebo controlled, double-blinded randomized controlled trial to test the hypothesis that local PEG administration can enhance sensory nerve regeneration following digital nerve transection compared to surgery alone.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04270019
Study type Interventional
Source Nova Scotia Health Authority
Contact
Status Withdrawn
Phase Phase 1/Phase 2
Start date June 26, 2020
Completion date September 15, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01437332 - Molecular Mediators of Nerve Injury Signaling N/A
Completed NCT03624426 - Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery N/A
Recruiting NCT04662320 - Promoting Healing Of Nerves Through Electrical Stimulation N/A
Active, not recruiting NCT04144972 - Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain N/A
Completed NCT02960516 - MRI Diffusion Tensor Tractography to Monitor Peripheral Nerve Recovery After Severe Crush or Cut/Repair Nerve Injury
Completed NCT05589324 - Effects of 3D Printing Writing Assisitive Device on Feasibility in Patients With Nerve Injury
Recruiting NCT03970161 - Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy N/A
Completed NCT01533337 - Free Dorsal Digital Flap for Reconstruction of Volar Soft Tissue Defect of Digits N/A
Completed NCT01528397 - Reconstruction of Proper Digital Nerve Defects in the Thumb Using a Pedicled Nerve Graft N/A
Enrolling by invitation NCT05080608 - Nerve Injury in the Hand, an Interview Study
Completed NCT03881462 - Deltoid Muscle Contribution to Shoulder Function N/A
Completed NCT05302141 - Effects of Assistive Device on ADL Function in Patients With Nerve Injury N/A
Terminated NCT01751503 - Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer N/A
Recruiting NCT05365282 - Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study
Active, not recruiting NCT03701581 - 4-aminopyridine Treatment for Nerve Injury Phase 2/Phase 3
Completed NCT04420689 - A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery Phase 1/Phase 2
Recruiting NCT05884125 - Promoting Healing of Injured Nerves With Electrical Stimulation Therapy N/A
Recruiting NCT05611983 - Experience and Feasibility of Methods for Early Sensory Training N/A
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT03701685 - A Comparison of the Littler Flap With the Bipedicled Nerve Flap N/A